PubMed

Immunologic Markers as Predictors of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in HIV and Tuberculosis Coinfected Persons in Thailand.

Tieu HV, Ananworanich J, Avihingsanon A, Apateerapong W, Sirivichayakul S, Siangphoe U, Klongugkara S, Boonchokchai B, Hammer SM, Manosuthi W.

AIDS Res Hum Retroviruses. 2009 Nov 3. [Epub ahead of print]PMID: 19886838 [PubMed - as supplied by publisher]Related articles

Poor agreement between 2 assays for measuring low levels of HIV-1 viral load.

Montaner JS, Richman DD, Hammer SM; International AIDS Society-USA Antiretroviral Guidelines Panel.

Clin Infect Dis. 2009 Oct 15;49(8):1283-4. No abstract available. PMID: 19780662 [PubMed - indexed for MEDLINE]Related articles

Combining Google Earth and GIS mapping technologies in a dengue surveillance system for developing countries.

Chang AY, Parrales ME, Jimenez J, Sobieszczyk ME, Hammer SM, Copenhaver DJ, Kulkarni RP.

Int J Health Geogr. 2009 Jul 23;8:49.PMID: 19627614 [PubMed - indexed for MEDLINE]Related articlesFree article

The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAART.

Castor D, Vlahov D, Hoover DR, Berkman A, Wu YF, Zeller B, Brechtl J, Hammer SM.

J Med Virol. 2009 Aug;81(8):1323-35.PMID: 19551816 [PubMed - indexed for MEDLINE]Related articles

Advances in antiretroviral therapy.

Wilkin TJ, Taylor B, Olender S, Hammer SM.

Top HIV Med. 2009 Apr-May;17(2):68-88.PMID: 19401609 [PubMed - indexed for MEDLINE]Related articlesFree article

Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy.

Coovadia A, Hunt G, Abrams EJ, Sherman G, Meyers T, Barry G, Malan E, Marais B, Stehlau R, Ledwaba J, Hammer SM, Morris L, Kuhn L.

Clin Infect Dis. 2009 Feb 15;48(4):462-72.PMID: 19133804 [PubMed - indexed for MEDLINE]Related articles

The challenge of HIV-1 subtype diversity.

Taylor BS, Hammer SM.

N Engl J Med. 2008 Oct 30;359(18):1965-6. No abstract available. PMID: 18971501 [PubMed - indexed for MEDLINE]Related articles

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Hammer SM, Eron JJ Jr, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA; International AIDS Society-USA.

JAMA. 2008 Aug 6;300(5):555-70.PMID: 18677028 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.

Hirsch MS, Günthard HF, Schapiro JM, Brun-Vézinet F, Clotet B, Hammer SM, Johnson VA, Kuritzkes DR, Mellors JW, Pillay D, Yeni PG, Jacobsen DM, Richman DD; International AIDS Society-USA.

Top HIV Med. 2008 Aug-Sep;16(3):266-85.PMID: 19856548 [PubMed]Free article

HIV vaccine research: the way forward.

Fauci AS, Johnston MI, Dieffenbach CW, Burton DR, Hammer SM, Hoxie JA, Martin M, Overbaugh J, Watkins DI, Mahmoud A, Greene WC.

Science. 2008 Jul 25;321(5888):530-2.PMID: 18653883 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.

Hirsch MS, Günthard HF, Schapiro JM, Brun-Vézinet F, Clotet B, Hammer SM, Johnson VA, Kuritzkes DR, Mellors JW, Pillay D, Yeni PG, Jacobsen DM, Richman DD.

Clin Infect Dis. 2008 Jul 15;47(2):266-85.PMID: 18549313 [PubMed - indexed for MEDLINE]Related articles

Advances in antiretroviral therapy.

Wilkin TJ, Taylor B, Olender S, Hammer SM.

Top HIV Med. 2008 Mar-Apr;16(1):31-60.PMID: 18441381 [PubMed - in process]Related articlesFree article

The challenge of HIV-1 subtype diversity.

Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM.

N Engl J Med. 2008 Apr 10;358(15):1590-602. Review. No abstract available. Erratum in: N Engl J Med. 2008 Oct 30;359(18):1965-6. N Engl J Med. 2008 Oct 30;359(18):1972. PMID: 18403767 [PubMed - indexed for MEDLINE]Related articlesFree article

Advances in antiretroviral therapy.

Jones J, Taylor B, Wilkin TJ, Hammer SM.

Top HIV Med. 2007 Apr-May;15(2):48-82.PMID: 17485787 [PubMed - indexed for MEDLINE]Related articlesFree article

Nucleoside analogue reverse transcriptase inhibitor options: a re-examination of the class.

Hammer SM.

Top HIV Med. 2006 Oct-Nov;14(4):140-3. Review.PMID: 17114828 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.

Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding PA; International AIDS Society--USA Panel.

Top HIV Med. 2006 Aug-Sep;14(3):827-43.PMID: 17016878 [PubMed]Related articlesFree article

Amdoxovir versus placebo with enfuvirtide plus optimized background therapy for HIV-1-infected subjects failing current therapy (AACTG A5118).

Gripshover BM, Ribaudo H, Santana J, Gerber JG, Campbell TB, Hogg E, Jarocki B, Hammer SM, Kuritzkes DR; A5118 Team.

Antivir Ther. 2006;11(5):619-23.PMID: 16964830 [PubMed - indexed for MEDLINE]Related articles

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding PA; International AIDS Society-USA panel.

JAMA. 2006 Aug 16;296(7):827-43.PMID: 16905788 [PubMed - indexed for MEDLINE]Related articlesFree article

Advances in antiretroviral therapy.

Sobieszczyk ME, Jones J, Wilkin T, Hammer SM.

Top HIV Med. 2006 Mar-Apr;14(1):36-62.PMID: 16641526 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical practice. Management of newly diagnosed HIV infection.

Hammer SM.

N Engl J Med. 2005 Oct 20;353(16):1702-10. Review. No abstract available. PMID: 16236741 [PubMed - indexed for MEDLINE]Related articles

Patents versus patients? Antiretroviral therapy in India.

Havlir DV, Hammer SM.

N Engl J Med. 2005 Aug 25;353(8):749-51. No abstract available. PMID: 16120852 [PubMed - indexed for MEDLINE]Related articles

Single-dose nevirapine and drug resistance: the more you look, the more you find.

Hammer SM.

J Infect Dis. 2005 Jul 1;192(1):1-3. Epub 2005 Jun 1. No abstract available. PMID: 15942885 [PubMed - indexed for MEDLINE]Related articles

Advances in antiretroviral therapy.

Sobieszczyk ME, Talley AK, Wilkin T, Hammer SM.

Top HIV Med. 2005 Mar-Apr;13(1):24-44.PMID: 15849370 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals.

Acosta EP, Wu H, Hammer SM, Yu S, Kuritzkes DR, Walawander A, Eron JJ, Fichtenbaum CJ, Pettinelli C, Neath D, Ferguson E, Saah AJ, Gerber JG; Adult AIDS Clinical Trials Group 5055 Protocol Team.

J Acquir Immune Defic Syndr. 2004 Nov 1;37(3):1358-66.PMID: 15483465 [PubMed - indexed for MEDLINE]Related articles

HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388.

Demeter LM, Ribaudo HJ, Erice A, Eshleman SH, Hammer SM, Hellmann NS, Fischl MA; AIDS Clinical Trials Group Protocol 388.

Clin Infect Dis. 2004 Aug 15;39(4):552-8. Epub 2004 Jul 30.PMID: 15356820 [PubMed - indexed for MEDLINE]Related articles

Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine.

Coplan PM, Cook JR, Carides GW, Heyse JF, Wu AW, Hammer SM, Nguyen BY, Meibohm AR, DiNubile MJ; AIDS Clinical Trials Group 320 Study Team.

Clin Infect Dis. 2004 Aug 1;39(3):426-33. Epub 2004 Jul 19.PMID: 15307012 [PubMed - indexed for MEDLINE]Related articles

Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections.

Sobieszczyk ME, Furuya EY, Hay CM, Pancholi P, Della-Latta P, Hammer SM, Kubin CJ.

J Antimicrob Chemother. 2004 Aug;54(2):566-9. Epub 2004 Jul 21.PMID: 15269195 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

Yeni PG, Hammer SM, Hirsch MS, Saag MS, Schechter M, Carpenter CC, Fischl MA, Gatell JM, Gazzard BG, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Schooley RT, Thompson MA, Vella S, Volberding PA.

JAMA. 2004 Jul 14;292(2):251-65.PMID: 15249575 [PubMed - indexed for MEDLINE]Related articles

Advances in antiretroviral therapy. Highlights of the 11th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2004, San Francisco, California, USA.

Sobieszczyk ME, Coakley EP, Wilkin TJ, Hammer SM.

Top HIV Med. 2004 Mar-Apr;12(1):9-29.PMID: 15111727 [PubMed - indexed for MEDLINE]Related articlesFree article

Detection of drug-resistant minority variants of HIV-1 during virologic failure of indinavir, lamivudine, and zidovudine.

Dykes C, Najjar J, Bosch RJ, Wantman M, Furtado M, Hart S, Hammer SM, Demeter LM.

J Infect Dis. 2004 Mar 15;189(6):1091-6. Epub 2004 Mar 1.PMID: 14999613 [PubMed - indexed for MEDLINE]Related articles

A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir.

Hammer SM, Bassett R, Squires KE, Fischl MA, Demeter LM, Currier JS, Mellors JW, Morse GD, Eron JJ, Santana JL, DeGruttola V; ACTG 372B/D Study Team.

Antivir Ther. 2003 Dec;8(6):507-18. No abstract available. PMID: 14760884 [PubMed - indexed for MEDLINE]Related articles

Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigm.

Moatti JP, N'Doye I, Hammer SM, Hale P, Kazatchkine M.

Nat Med. 2003 Dec;9(12):1449-52. No abstract available. PMID: 14647513 [PubMed - indexed for MEDLINE]Related articles

A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease.

Fischl MA, Ribaudo HJ, Collier AC, Erice A, Giuliano M, Dehlinger M, Eron JJ Jr, Saag MS, Hammer SM, Vella S, Morse GD, Feinberg JE, Demeter LM, Eshleman SH; Adult AIDS Clinical Trials Group 388 Study Team.

J Infect Dis. 2003 Sep 1;188(5):625-34. Epub 2003 Aug 15. Erratum in: J Infect Dis. 2003 Oct 1;188(7):1083. PMID: 12934177 [PubMed - indexed for MEDLINE]Related articles

Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel.

Hirsch MS, Brun-Vézinet F, Clotet B, Conway B, Kuritzkes DR, D'Aquila RT, Demeter LM, Hammer SM, Johnson VA, Loveday C, Mellors JW, Richman DD; International AIDS Society-USA Resistance Testing Guidelines Panel.

Top HIV Med. 2003 Jul-Aug;11(4):150-4.PMID: 12876334 [PubMed - indexed for MEDLINE]Related articlesFree article

What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials.

Gilbert PB, DeGruttola VG, Hudgens MG, Self SG, Hammer SM, Corey L.

J Infect Dis. 2003 Jul 15;188(2):179-93. Epub 2003 Jul 1.PMID: 12854072 [PubMed - indexed for MEDLINE]Related articles

Advances in antiretroviral therapy.

Albrecht MA, Wilkin TJ, Coakley EP, Hammer SM.

Top HIV Med. 2003 May-Jun;11(3):97-127. Review. No abstract available. PMID: 12837969 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

Hirsch MS, Brun-Vézinet F, Clotet B, Conway B, Kuritzkes DR, D'Aquila RT, Demeter LM, Hammer SM, Johnson VA, Loveday C, Mellors JW, Jacobsen DM, Richman DD.

Clin Infect Dis. 2003 Jul 1;37(1):113-28. Epub 2003 Jun 23.PMID: 12830416 [PubMed - indexed for MEDLINE]Related articles

Indinavir, efavirenz, and abacavir pharmacokinetics in human immunodeficiency virus-infected subjects.

DiCenzo R, Forrest A, Squires KE, Hammer SM, Fischl MA, Wu H, Cha R, Morse GD; Adult AIDS Clinical Trials Group Protocol 368/886 Study Team.

Antimicrob Agents Chemother. 2003 Jun;47(6):1929-35.PMID: 12760869 [PubMed - indexed for MEDLINE]Related articlesFree article

HIV Drug Resistance: Implications for Management.

Hammer SM.

Top HIV Med. 2002 Nov;10(5):10-15.PMID: 12717050 [PubMed - as supplied by publisher]Related articlesFree article

Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy.

Tierney C, Lathey JL, Christopherson C, Bettendorf DM, D'Aquila RT, Hammer SM, Katzenstein DA.

J Infect Dis. 2003 Jan 1;187(1):144-8. Epub 2002 Dec 13.PMID: 12508159 [PubMed - indexed for MEDLINE]Related articles

Population pharmacokinetics and pharmacodynamics of efavirenz, nelfinavir, and indinavir: Adult AIDS Clinical Trial Group Study 398.

Pfister M, Labbé L, Hammer SM, Mellors J, Bennett KK, Rosenkranz S, Sheiner LB; Adult AIDS Clinical Trial Group Study 398.

Antimicrob Agents Chemother. 2003 Jan;47(1):130-7.PMID: 12499180 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacokinetics of amprenavir.

Pfister M, Labbé L, Lu JF, Hammer SM, Mellors J, Bennett KK, Rosenkranz S, Sheiner LB; AIDS Clinical Trial Group Protocol 398 Investigators.

Clin Pharmacol Ther. 2002 Aug;72(2):133-41.PMID: 12189360 [PubMed - indexed for MEDLINE]Related articles

Cornell/amfAR Symposium. Strategies of antiretroviral therapy.

Hammer SM.

AIDS Read. 2002 Jun;12(6):257-60, 262.PMID: 12138880 [PubMed - indexed for MEDLINE]Related articles

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

Yeni PG, Hammer SM, Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Volberding PA.

JAMA. 2002 Jul 10;288(2):222-35. Review. Erratum in: JAMA. 2003 Jan-Feb;11(1):32. PMID: 12095387 [PubMed - indexed for MEDLINE]Related articles

Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial.

Hammer SM, Vaida F, Bennett KK, Holohan MK, Sheiner L, Eron JJ, Wheat LJ, Mitsuyasu RT, Gulick RM, Valentine FT, Aberg JA, Rogers MD, Karol CN, Saah AJ, Lewis RH, Bessen LJ, Brosgart C, DeGruttola V, Mellors JW; AIDS Clinical Trials Group 398 Study Team.

JAMA. 2002 Jul 10;288(2):169-80.PMID: 12095381 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiretroviral guidelines for resource-limited settings: the WHO's public health approach.

Hammer SM, Türmen T, Vareldzis B, Perriens J.

Nat Med. 2002 Jul;8(7):649-50. No abstract available. PMID: 12091891 [PubMed - indexed for MEDLINE]Related articles

Increasing choices for HIV therapy.

Hammer SM.

N Engl J Med. 2002 Jun 27;346(26):2022-3. No abstract available. PMID: 12087136 [PubMed - indexed for MEDLINE]Related articles

Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliter.

Demeter LM, Bosch RJ, Coombs RW, Fiscus S, Bremer J, Johnson VA, Erice A, Jackson JB, Spector SA, Squires KM, Fischl MA, Hughes MD, Hammer SM.

J Clin Microbiol. 2002 Jun;40(6):2089-94.PMID: 12037070 [PubMed - indexed for MEDLINE]Related articlesFree article

HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients.

Falloon J, Ait-Khaled M, Thomas DA, Brosgart CL, Eron Jr JJ, Feinberg J, Flanigan TP, Hammer SM, Kraus PW, Murphy R, Torres R, Masur H; CNA2007 Study Team.

AIDS. 2002 Feb 15;16(3):387-96.PMID: 11834950 [PubMed - indexed for MEDLINE]Related articles

Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy.

Lathey JL, Tierney C, Chang SY, D'Aquila RT, Bettendorf DM, Alexander HC, Santini CD, Hughes AM, Barroga CF, Spector SA, Landes JE, Hammer SM, Katzenstein DA.

J Infect Dis. 2001 Dec 1;184(11):1402-11. Epub 2001 Nov 13.PMID: 11709782 [PubMed - indexed for MEDLINE]Related articles